Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple breathing device may boost liver and lung health in elderly men

NCT ID NCT07193082

Disease control Sponsor: Gümüşhane Universıty Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a 4-week program of inspiratory muscle training (using a POWERbreathe® device) could improve diaphragm thickness, reduce fatty liver, and increase aerobic capacity in 30 healthy men aged 60-80. Participants were split into a training group and a control group. The goal is to see if this simple, drug-free exercise can help counteract age-related declines in breathing and liver health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Inspiratory muscle training using a POWERbreathe® device
What this could lead to
If it works, this simple breathing exercise could offer a drug-free way to improve breathing, liver health, and physical fitness in older men.
What could go wrong
This is a small, short-term study with only 30 participants. Results may not apply to women or people with health conditions, and the effects may not last beyond 4 weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Jun 2025

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 80 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion: * Male, aged 60-80 years * Healthy, without severe comorbidities * Voluntary participation with informed consent Exclusion: * Known respiratory or cardiovascular disease * Neurological or musculoskeletal disorders limiting participation * Recent abdominal or thoracic surgery * Inability to comply with training protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

fatty liver disease Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Aging Fatty liver Inspiratory muscle weakness Reduced functional capacity

Contacts and locations

Locations

  • Gumushane Univetsity

    Gümüşhane, Kelkit, 29600, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.